Literature DB >> 21104984

Analysis of protein prenylation in vitro and in vivo using functionalized phosphoisoprenoids.

Uyen T T Nguyen1, Yaowen Wu, Andrew Goodall, Kirill Alexandrov.   

Abstract

Post-translational modifications (PTMs) expand the number of protein isoforms in eukaryotic proteome by orders of magnitude. Protein modification with isoprenoid lipids is a common PTM affecting hundreds of proteins controlling the transport of information and materials into, through, and out of the eukaryotic cell. In this modification, a soluble phosphoisoprenoid such as farnesyl (C15) or geranylgeranyl (C20) pyrophosphate moiety is recruited by one of three protein prenyltransferases to covalently modify a C-terminal cysteine(s) in a target protein. The three mammalian prenyltransferases are farnesyltransferase (FTase), geranylgeranyltransferase type I (GGTase I), and Rab geranylgeranyl transferase (also termed geranylgeranyltransferase type II - GGTase II). In this unit, synthetic isoprenoids conjugated to either a fluorophore or biotin group are used to assay the activity of protein prenyltransferases in vitro or to affinity tag prenylatable proteins in cell lysates. These protocols and their modifications can be used to study the mechanisms of protein prenylation, identify prenylation targets, and characterize inhibitors of protein prenyltransferases in vitro and in vivo.
© 2010 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21104984     DOI: 10.1002/0471140864.ps1403s62

Source DB:  PubMed          Journal:  Curr Protoc Protein Sci        ISSN: 1934-3655


  7 in total

1.  Membrane protein transport in photoreceptors: the function of PDEδ: the Proctor lecture.

Authors:  Wolfgang Baehr
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-30       Impact factor: 4.799

Review 2.  Protein Prenyltransferases and Their Inhibitors: Structural and Functional Characterization.

Authors:  Aleksandra Marchwicka; Daria Kamińska; Mohsen Monirialamdari; Katarzyna M Błażewska; Edyta Gendaszewska-Darmach
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

Review 3.  The prenyl-binding protein PrBP/δ: a chaperone participating in intracellular trafficking.

Authors:  Houbin Zhang; Ryan Constantine; Jeanne M Frederick; Wolfgang Baehr
Journal:  Vision Res       Date:  2012-08-29       Impact factor: 1.886

4.  Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient.

Authors:  Nicolas Cereso; Marie O Pequignot; Lorenne Robert; Fabienne Becker; Valerie De Luca; Nicolas Nabholz; Valerie Rigau; John De Vos; Christian P Hamel; Vasiliki Kalatzis
Journal:  Mol Ther Methods Clin Dev       Date:  2014-04-02       Impact factor: 6.698

5.  The Biological Activity of AAV Vectors for Choroideremia Gene Therapy Can Be Measured by In Vitro Prenylation of RAB6A.

Authors:  Maria I Patrício; Alun R Barnard; Christopher I Cox; Clare Blue; Robert E MacLaren
Journal:  Mol Ther Methods Clin Dev       Date:  2018-03-28       Impact factor: 6.698

6.  Towards the systematic mapping and engineering of the protein prenylation machinery in Saccharomyces cerevisiae.

Authors:  Viktor Stein; Marta H Kubala; Jason Steen; Sean M Grimmond; Kirill Alexandrov
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

7.  Drosophila Tempura, a novel protein prenyltransferase α subunit, regulates notch signaling via Rab1 and Rab11.

Authors:  Wu-Lin Charng; Shinya Yamamoto; Manish Jaiswal; Vafa Bayat; Bo Xiong; Ke Zhang; Hector Sandoval; Gabriela David; Stephen Gibbs; Hsiang-Chih Lu; Kuchuan Chen; Nikos Giagtzoglou; Hugo J Bellen
Journal:  PLoS Biol       Date:  2014-01-28       Impact factor: 8.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.